Aehr Test Systems: Form 10-Q for the period ended Aug 30, 2024
Filed with the SEC on Oct 11, 2024 and accepted by EDGAR at Oct 11, 2024, 17:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-08-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-06-01 to 2024-08-30 | $13.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-06-01 to 2024-08-30 | $6.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-06-01 to 2024-08-30 | $7.1m | us-gaap:GrossProfit |
| Research and development | 3 months2024-06-01 to 2024-08-30 | $2.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-06-01 to 2024-08-30 | $4.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-06-01 to 2024-08-30 | $159.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-06-01 to 2024-08-30 | $154.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-06-01 to 2024-08-31 | $660.0k | us-gaap:NetIncomeLoss |
| Net income | 3 months2024-06-01 to 2024-08-30 | $660.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-06-01 to 2024-08-31 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 3 months2024-06-01 to 2024-08-30 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-06-01 to 2024-08-31 | $0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 3 months2024-06-01 to 2024-08-30 | $0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-06-01 to 2024-08-31 | 29,632,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 3 months2024-06-01 to 2024-08-30 | 29,632,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-06-01 to 2024-08-30 | $2.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-06-01 to 2024-08-30 | $197.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-08-30 | $37.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-08-30 | $92.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-08-30 | $145.9m | us-gaap:Assets |
| Current liabilities | At period end2024-08-30 | $15.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-08-30 | $23.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-08-30 | $122.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001654954-24-012913. Last ingested by Listed: Oct 29, 2026, 18:22 ET. Listed shows no prices and gives no investment advice.